| 產(chǎn)品名稱(chēng) | Perifosine - KRX 0401 | D 21266 |
| 產(chǎn)品貨號(hào) | Axon 1663 CAS [157716-52-4] MF C25H52NO4PMW 461.66 Purity: 98% Soluble in water Description Orally available Akt inhibitor that inhibits Akt activation in the PI3K pathway References Certificates Categories Extra info JJ Gills and PA Dennis. Perifosine: update on a novel Akt inhibitor.?Curr. Oncol. Rep. 2009, 11(2), 102-110. ? SB Kondapaka et al. Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation. Mol. Cancer Ther. 2003, 2(11), 1093-1103. ? V Patel et al. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity (...). Cancer Res. 2002, 062(5), 1401-1409. Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology Akt PI3K-Akt-mTOR EC 2.7.11.1 PI3K/Akt inhibitor Chemical name 1,1-dimethylpiperidinium-4-yl octadecyl phosphate Parent CAS No. [157716-52-4] Order Size Unit Price Stock 5 mg €85.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢(xún)價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
Perifosine - KRX 0401 | D 21266Axon 1663 CAS [157716-52-4] MF C25H52NO4P
Description
Orally available Akt inhibitor that inhibits Akt activation in the PI3K pathway
PI3K/Akt inhibitor
Chemical name1,1-dimethylpiperidinium-4-yl octadecyl phosphate Parent CAS No.[157716-52-4] |
| 產(chǎn)品資料 |
